<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 3; Issue 5</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(Sep-Oct, 2022)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>Levothyroxine in Women with Clinical Hypothyroidism Undergoing In-Vitro Fertilization: A Case Report</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>5</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Amani</FirstName>
          <LastName>Alrifai</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Zeinab</FirstName>
          <LastName>Melhem</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Yusef</FirstName>
          <LastName>Hazimeh</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Hypothyroidism is characterized by a high thyroid stimulating hormone (TSH) level and low thyroid hormones (T3 and/or T4). Abnormalities in ovulation, infertility, and recurrent pregnancy losses can arouse due to hypothyroidism. Pregnancy is a physiological status that mandates an increase in levothyroxine doses for euthyroid women with primary hypothyroidism. Serum levels of thyroid stimulating hormone can increase significantly during In-Vitro fertilization among women treated for hypothyroidism, and hypothyroidism that is either undiagnosed or under-treated can contribute to infertility and result in miscarriages. Throughout the literature, artificial pregnancies, In-Vitro fertilization (IVF) mainly, have required a more aggressive increase in the levothyroxine dose. Here, we report the case of a 40-year old hypothyroid woman with a history of nine abortions after IVF procedures who presented for treatment of her hypothyroidism. We present in details the modification process of her levothyroxine dose according to monthly TSH levels starting from her ninth miscarriage through her tenth IVF procedure and all throughout the pregnancy, until the successful delivery of a healthy baby.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>Pregnancy,Hypothyroidism,Levothyroxine,In-Vitro Fertilization,Abortion</Keywords>
      <URLs>
        <Abstract>https://www.jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=14089&amp;title=Levothyroxine in Women with Clinical Hypothyroidism Undergoing In-Vitro Fertilization: A Case Report</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351: 241–249.&#13;
&#13;
Busnelli A, Vannucchi G, Paffoni A, Faulisi S, Fugazzola L, Fedele L, Somigliana E. Levothyroxine dose adjustment in hypothyroid women achieving pregnancy through IVF. Eur J Endocrinol 2015; 173: 417-424.&#13;
&#13;
Frand;ouml;hlich E and Wahl R. Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases. Front Immunol 2017; 8: 521.&#13;
&#13;
Hallengren B, Lantz M, Andreasson B, Grennert L. Pregnant women on thyroxine substitution are often dysregulated in early pregnancy. Thyroid 2009; 19: 391–394.&#13;
&#13;
Kaplan M M. Management of thyroxine therapy during pregnancy. Endocr Pract 1996; 2: 281–286.&#13;
&#13;
Kashi Z, Bahar A, Akha O, Hassanzade S, Esmaeilisaraji L, Hamzehgardeshi Z. Levothyroxine Dosage Requirement During Pregnancy in Well-Controlled Hypothyroid Women: A Longitudinal Study. Glob J Health Sci 2015; 8: 227-233.&#13;
&#13;
Kiran Z, Khalid W, Sheikh A, Islam N. Levothyroxine dosages during pregnancy among hypothyroid women. An experience from a tertiary care center of Karachi, Pakistan, based on data from Maternal Hypothyroidism on Pregnancy Outcomes Study (MHPO-5). BMC Res Notes 2022; 15: 92.&#13;
&#13;
Leung AM. Thyroid function in pregnancy. J Trace Elem Med Biol 2012; 26: 137-140.&#13;
&#13;
Mandel SJ, Larsen PR, Seely EW, Brent GA. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 1990; 323: 91–96.&#13;
&#13;
Mandel SJ. Hypothyroidism and chronic autoimmune thyroiditis in the pregnant state: Maternal aspects. Best Pract Res Clin Endocrinol Metab 2004; 18: 213–224.&#13;
&#13;
Pekonen F, Teramo K, Ikonen E, Osterlund K, Makinen T, Lamberg BA. Women on thyroid hormone therapy: pregnancy course, fetal outcome, and amniotic fluid thyroid hormone level. Obstet Gynecol 1984; 63: 635–638.&#13;
&#13;
Scoccia B, Demir H, Kang Y, Fierro MA, Winston NJ. In Vitro fertilization pregnancy rates in levothyroxine-treated women with hypothyroidism compared to women without thyroid dysfunction disorders. Thyroid 2012; 22: 631-636.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>